Former President Joe Biden Diagnosed with Aggressive Prostate Cancer

Zero Prostate Cancer Responds to Biden's Diagnosis

On May 19, 2025, a sobering announcement was made regarding former President Joe Biden's health: he has been diagnosed with an aggressive form of prostate cancer. The diagnosis, which includes a Gleason score of 9, indicates that his cancer is highly aggressive. According to a spokesperson from Biden's family, the disease has unfortunately metastasized to the bone, raising significant concerns for the former leader. This news has sent ripples of concern throughout the nation, drawing attention to the realities of prostate cancer, a condition that affects many men across the United States.

Understanding the Gleason Score

For those unfamiliar, a Gleason score helps medical professionals gauge the aggressiveness of prostate cancer based on how abnormal the cell structures look under a microscope. A score of 9 is considered critical, highlighting the seriousness of this diagnosis for Biden. However, there is some encouraging news: according to Dr. Alicia Morgans, the Medical Chair of the Board of Directors at ZERO Prostate Cancer, Biden's cancer appears to be hormone-sensitive. This could show a positive response to standard treatments such as androgen deprivation therapy (ADT), which works by reducing testosterone levels—something that cancer cells need to thrive.

Prostate Cancer Statistics

Prostate cancer remains a leading cause of cancer-related deaths among men, with a man diagnosed every two minutes in the U.S. This stark statistic underscores the need for increased awareness and early detection of prostate cancer.

Furthermore, the reality of the disease emphasizes that no man—regardless of status or prominence—is immune. Courtney Bugler, President and CEO of ZERO Prostate Cancer, expressed this sentiment, reminding everyone that prostate cancer can affect anyone at any time. Bugler encourages men to leverage this moment as a wake-up call to engage in discussions about their health with physicians, particularly regarding the importance of early detection through the PSA blood test.

ZERO Prostate Cancer's Role

For nearly three decades, ZERO has been instrumental in advocating for those impacted by prostate cancer. The organization, originally known as the National Prostate Cancer Coalition, provides resources, educational initiatives, and vital support networks for patients and their families. They were also involved in launching the Cancer Moonshot initiative during Biden's vice presidency. This year, ZERO launched its ambitious program, Blitz The Barriers, aimed at saving 100,000 lives by 2035 through increased access to screenings and breakthroughs in treatments.

As Bugler remarked, the statistics are alarming: this year will see over 300,000 new prostate cancer diagnoses, and more than 35,000 men are expected to lose their lives to this disease. With so many lives on the line, the importance of confronting barriers to early detection, treatment, and beneficial care cannot be overstated.

Moving Forward

For anyone interested in learning more about prostate cancer screening, gaining insight into the implications of both early and advanced-stage diagnoses, and accessing resources for patients or caregivers, resources are available online. Interested individuals can visit zerocancer.org for comprehensive information.

In conclusion, the diagnosis of former President Biden has put a spotlight on prostate cancer, serving as a reminder of the need for proactive health measures amongst men. The resilient spirit of those battling this disease is amplified by advocacy and community support, providing hope for a brighter future in the fight against prostate cancer.